Cross Research S.A.: Clinical Trials

22 trials sponsored by Cross Research S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed. 22 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 122Completed 22

Follow Cross Research S.A.: new trials by email

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Palatability Study of Five Formulations of Benzydamine HCl Lozenges
benzydamine HCl - Healthy Volunteers, Palatability
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A1202025-04-132025-09-30
Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.
MAD0004J08, Placebo - COVID-19 Virus Disease
Phase 1CompletedToscana Life Sciences Sviluppo s.r.l.302021-03-012022-04-27
Riluzole Orodispersible Film Replicate Bioavailability
Riluzole 50 mg orodispersible film, Rilutek® 50 mg riluzole tablets - Healthy Participants
Phase 1CompletedCross Research S.A.542021-01-152025-05-02
Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions
Trazodone HCl - new polymer, Trazodone HCl - Contramid® - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A282020-02-172021-11-29
Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution
Ketoprofen Lysine, Ketoprofen Oral Product - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A362018-07-232020-12-21
Bioequivalence of Flurbiprofen Lozenge vs Strepfen
Flurbiprofen Test 8.75 MG, Flurbiprofen Reference 8.75 MG - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A242018-06-192020-12-17
A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer
Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% + mucus adhesive polymer, Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A262017-11-142020-08-05
Safinamide Steady State Interaction With Rosuvastatin
100 mg safinamide, 20 mg rosuvastatin calcium period 1, 20 mg rosuvastatin calcium period 2 - Healthy
Phase 1CompletedCross Research S.A.242017-05-222017-08-01
Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers
Trazodone 20 mg, Trazodone 60 mg, Trazodone 140 mg - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A202017-03-202020-07-31
Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup
SCMC-lys powder 1.35 g, Fluifort® syrup - Bronchitis
Phase 1CompletedDompé Farmaceutici S.p.A302016-07-042024-11-18
Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet
Ibuprofen 200 mg/5 mL oral suspension, MOMENT 200 mg coated tablet - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A602016-06-012016-09-15
Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet
Ibuprofen 400 mg/10 mL oral suspension, MOMENT 400 mg coated tablet - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A602016-05-012016-09-15
Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg
Paracetamol 1000 mg/codeine phosphate hemihydrate 30 mg tablet, Paracetamol 500 mg/codeine phosphate hemihydrate 30 mg tablet - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A462016-04-012016-09-16
Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary
Econazole nitrate 150 mg plus Benzydamine HCl 6 mg vaginal pessary, Placebo plus Econazole nitrate 150 mg vaginal pessary, Placebo plus Benzydamine HCl 6 mg vaginal pessary - Healthy Women
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A492016-03-042017-02-07
Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
tradipitant, Midazolam - Healthy Volunteers
Phase 1CompletedVanda Pharmaceuticals242015-11-012016-04-27
Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream
Econazole nitrate 1% plus Benzydamine HCl 0.12% intravaginal cream, Placebo plus Econazole nitrate 1% intravaginal cream, Placebo plus Benzydamine HCl 0.12% intravaginal cream - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A482015-09-012018-01-17
Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers
Diclofenac sodium, Diclofenac sodium and safinamide - Healthy
Phase 1CompletedZambon SpA242015-05-012016-04-15
Ibuprofen (MOMENT ACT ANALGESIC Granules) Pharmacokinetic Study
Ibuprofen - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A242015-02-012015-06-26
Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution
KSL 40 mg, OKi® 80 mg - Pain Disorders
Phase 1CompletedDompé Farmaceutici S.p.A302014-11-262024-04-19
Safety Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 & Piperaquine to Healthy Subjects
100mg OZ439 single oral dose, Placebo, 300 mg OZ439 single oral dose - Healthy
Phase 1CompletedMedicines for Malaria Venture592012-09-012015-01-21

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Anthrax (1)  ·  Bronchitis (1)  ·  COVID-19 (1)  ·  Dysmenorrhea (1)  ·  Headache (1)  ·  Leukemia, Hairy Cell (1)  ·  Neuralgia (1)  ·  Somatoform Disorders (1)  ·  Toothache (1)

Interventions

Benzydamine (4)  ·  Ibuprofen (3)  ·  Econazole (2)  ·  Suspensions (2)  ·  Trazodone (2)  ·  safinamide (2)  ·  Acetaminophen (1)  ·  Cetylpyridinium (1)  ·  Diclofenac (1)  ·  Filgrastim (1)  ·  MAD0004J08 (1)  ·  Metered Dose Inhalers (1)  ·  Midazolam (1)  ·  Moxifloxacin (1)  ·  Powders (1)

Countries

Switzerland (20)  ·  Italy (1)

Top investigators

Milko Radicioni, MD (14)  ·  Andrea Paolini (1)  ·  Antonio Rusca, MD (1)  ·  Antonio Rusca, MD, FMH (1)  ·  Milko M Radicioni, MD PhD (1)  ·  Milko Radicioni (1)

Results publications

PMID 21615456, PMID 24555723, PMID 32410819, PMID 32488885, PMID 34473343, PMID 35477725